Bill Amsbaugh
InvestorPartner at Cure Ventures
Cambridge, Massachusetts
Writes $100K β $5M checks Β· typically $1.5M
Find your path to Bill
451 people in our graph share verified history with Bill β schools, employers, funds. One of them is your warm intro.
Javier SolterounlockedBill: together at Carnegie Mellon University (2011β2013)
Γ2Bill: together at Johnson & Johnson
Γ3Bill: together at Boston University
Γ4Bill: together at Carnegie Mellon University
About
Partner and Chief Technology Officer at Cure Ventures leading bioinformatics efforts, with 25 years combining analytical chemistry and computer science to accelerate drug discovery. Previously co-founded Precision Health Software and worked with Third Rock Ventures portfolio companies.
ContactΒ· self-published, not guessed
Experience
- Cure VenturesChief Technology Officer, Partnercurrent2021 β presentBoston, MA
- Precision HealthSoftCo-Founder, Chief Technology Officer2018 β 2021Boston, MA
- Convergence Life Science Technologies, LLCFounder & Managing Director2013 β 2021Massachusetts
- PTPCloud Architect2019 β 2021Norwood, MA
- Constellation PharmaceuticalsDirector of Automation & Information Technology2012 β 2014Cambridge, MA
- Constellation PharmaceuticalsAssociate Director of Automation and Information Technology2008 β 2012
- Ore Pharmaceuticals (formerly Gene Logic)Senior Manager2005 β 2008Cambridge, MA
- Johnson & Johnson (Formerly Transform Pharmaceuticals)Team Leader/Senior Developer2002 β 2005Lexington, MA
- Comverse Technology, IncLead Software Engineer1999 β 2002Wakefield, Massachusetts, United States
- Cabot CorporationAnalytical Chemist1998 β 1999Billerica, MA
Skills & more
Artificial Intelligence (AI)Machine LearningDrug Discovery21GenomicsBioinformaticsBiotechnology20Software Architectural DesignNatural Language Processing (NLP)Scientific ComputingLife Sciences9Cloud ComputingInformatics3
+5 more
Drug DevelopmentR&DIT StrategyChemistryPharmaceutical IndustryFrom Bill's professional profile.
Colleagues at Cure Ventures
Albert J. Robichaud
Partner at Cure Ventures
Annie Mitsak
Partner at Cure Ventures
Courtney Turner
Director of Finance at Cure Ventures
David Fallace
Managing Partner at Cure Ventures
Dr. Michael Aberman
Investor at Cure Ventures
Dr. Milenko Cicmil
Investor at Cure Ventures
Drew King
CFO and Partner at Cure Ventures
Jeffrey M. Jonas
Partner at Cure Ventures
Network4
David Fallace
Managing Partner at Cure Ventures
Drew King
CFO and Partner at Cure Ventures
Kenzie MacIsaac
Partner at Cure Ventures
May Han
Partner at Cure Ventures
Investors connected to Bill in public investor directories β a warm-intro map.
Frequently asked questions
- Who is Bill Amsbaugh?
- Partner and Chief Technology Officer at Cure Ventures leading bioinformatics efforts, with 25 years combining analytical chemistry and computer science to accelerate drug discovery. Previously co-founded Precision Health Software and worked with Third Rock Ventures portfolio companies.
- Where does Bill Amsbaugh work?
- Bill Amsbaugh is Partner at Cure Ventures.
- What check size does Bill Amsbaugh write?
- Bill Amsbaugh typically writes checks of $100K β $5M.
- Where did Bill Amsbaugh go to school?
- Bill Amsbaugh studied at Boston University (Master of Science (MS), Computer Science); Carnegie Mellon University (Certificate, SEI Software Architecture Professional); Boston University (Graduate Certificate, Digital Forensics).
Same school
Also attended Boston University554
Aydin SenkutFounder & Managing Partner at FelicisVinnie LauriaFounding Partner at Golden Gate VenturesJeff GrammerPartner at Rho VenturesGil GorenPartner at 83NorthJames LindenbaumCo-founder at HeavybitDave BiscegliaVenture Partner at Founder Collective
+ 548 more
Also attended Carnegie Mellon University730
Kai-Fu LeeChairman of Sinovation Ventures and CEO of 01.AILucy GuoCo-founder of Scale AI; founder & CEO of PassesGuillaume LampleCo-founder & Chief Scientist of Mistral AIJoshua XuCo-founder & CEO of HeyGenJavier SolteroSenior Venture Partner at Felicis VenturesAvi BharadwajInvestment Director at Intel Capital
+ 724 more
Also attended Western New England University9
Agathe BertrandSenior Associate, Wealth Management at Adams Street PartnersLarry DeroseFounder & CEO, AdvaStim, Inc. at AIFNans RivatVice President at PACE Healthcare CapitalKevin EknaianSenior Vice President, Head of Global Institutional and Workplace Retirement Sales at American Century Private InvestmentsDanielle CarrManaging Director of Human Resources at DeerpathCollin CollinsChief Scientific Officer (CSO) at Hexamer Therapeutics
+ 3 more
Shared employers
Also worked at PTP1
Also worked at Ore Pharmaceuticals (formerly Gene Logic)3
Also worked at Johnson & Johnson (Formerly Transform Pharmaceuticals)362
Teresa ChanChief Financial Officer at Felicis VenturesKarthik ArdhanareeswaranInvestor at GV (Google Ventures)KobeFinance Director at Hummingbird VenturesMickelFinance & Risk Management at Hummingbird VenturesHal PazInvestor at Khosla VenturesNiall O'DonnellManaging Director at RiverVest Venture Partners
+ 356 more




















































